Hansa Biopharma Nomination Committee formed
Lund, December 23, 2022. Hansa Biopharma today announced that the Nomination Committee has been formed in accordance with the principles adopted by the Annual General Meeting (AGM) on June 30, 2022 and has the following composition: · Natalie Berner representing Redmile Group · Jannis Kitsakis representing AP4 · Arne Myhrman representing Thomas Olausson As the conveyer of the Nomination Committee, Peter Nicklin, Chairman of the Board of Directors at Hansa Biopharma will be asked to summon the first meeting in the Nomination Committee. The function of the Nomination